entertainment -WSS

entertainment

author：knowledge 2025-09-29 01:54:46 Page View：6

Dozens of sickle cells in a whirlpool — coverage from STAT — Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Why we need to separate burnout from moral injury in health care
Next article： Medical records are filled with copy

explore

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Moderna says combo Covid

AlexHogan/STATModernaannouncedMondaythat,inaPhase3clinicaltrial,itscombinationCovid-19andinfluenzava

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Colonoscopy at 40? Study finds a possible benefit

Dr.PedroJoseGreer,right,preparingtodoacolonoscopyatMercyHospitalinMiami.LynneSladky/APNearly15percen